T-cell immunotherapy with a chimeric receptor against CD38 is effective in eradicating chemotherapy-resistant B-cell lymphoma cells overexpressing survivin induced by BMI-1

Detalles Bibliográficos
Autores principales: Bhattacharyya, J, Mihara, K, Kitanaka, A, Yanagihara, K, Kubo, T, Takei, Y, Kimura, A, Takihara, Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3389163/
https://www.ncbi.nlm.nih.gov/pubmed/22829977
http://dx.doi.org/10.1038/bcj.2012.21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3389163/
https://www.ncbi.nlm.nih.gov/pubmed/22829977
http://dx.doi.org/10.1038/bcj.2012.21

Ejemplares similares